We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
MASK (Mobile Airways Sentinel Network). La solución integral de ARIA por app móvil para la multimorbilidad de rinitis alérgica y asma.
- Authors
Larenas-Linnemann, Désirée; Mullol, Joaquim; Ivancevich, Juan Carlos; Antó, Josep M.; Cardona, Victoria; Dedeu, Toni; Rodríguez-González, Mónica; Huerta, Yunuen; Neffen, Hugo; Fuentes-Pérez, José Miguel; Rodríguez-Zagal, Eréndira; Valero, Antonio; Zernotti, Mario; Bartra, Joan; Alobid, Isam; Castillo-Vizuete, José Antonio; Dordal, Teresa; Hijano, Rafael; Picado, César; Sastre, Joaquín
- Abstract
The vast majority of patients with allergic rhinitis (AR) do not receive the proper management which is recommended by the guidelines, but they frequently self-medicate. MASK (Mobile Airways Sentinel Network) is an integral part of a project that is supported by the European Union against chronic diseases and focused on active and healthy aging. MASK represents the third phase of ARIA (Allergic Rhinitis and its Impact on Asthma), in which, by using a mobile application in a smart device, the objective is to guide the patient in the control of his/her multi-morbidity, AR and/or allergic conjunctivitis (AC) and/or asthma. The mobile app Allergy Diary by MACVIA-ARIA is free and it is available for both Android and iOS platforms. After it is downloaded to the patient's cell phone, it first requests some information about the patient's profile, allergic pathologies and medication; afterwards, through a visual analog scale, the patient is invited to determine the degree of affectation in the nose, eyes, and bronchi, and its influence on their productivity at work/school. After analyzing the data generated by filling the Allergy Diary, it became clear there is a new clinical entity: allergic rhinitis+ allergic conjunctivitis +asthma, with greater effect; in addition to a high level of self-medication: in general, the patient takes medication on days when symptoms are present. The app has already been deployed in 23 countries, including several Spanish-speaking countries.
- Publication
Revista Alergia de Mexico, 2019, Vol 66, Issue 1, p140
- ISSN
0002-5151
- Publication type
Article
- DOI
10.29262/ram.v66i1.578